Table 2

Relative hazards (95% CI) associated with progression to death

All deathsLiver related deaths
VariableRelative hazard95% CIpRelative hazard95% CIp
(a) Unadjusted
 Genotype 11.91(1.03–3.57)0.043.92(1.16–13.24)0.03
 HIV seroconversion2-150 7.60(4.63–12.37)0.00014.64(2.06–10.45)0.0002
 Age (y) at HCV infection
  <101.0
  10–192.08(0.96–4.51)0.061.59(0.29–8.7)0.06
  20–292.80(1.25–6.29)0.015.95(1.26–28.04)0.02
  >306.43(3.11–13.30)0.00019.18(2.05–41.06)0.004
 Time of first anti-HCV therapy2-150 0.71(0.32–1.58)0.411.22(0.40–3.74)0.72
(b) Adjusted
 HIV seroconversion2-150 19.47(9.22–41.10)0.000117.51(5.82–52.72)0.0001
 Age (y) at HCV infection
  <101.01.0
  10–190.99(0.39–2.53)0.9871.66(0.17–16.12)0.66
  20–293.47(1.40–8.630.00716.04(1.96–131.45)0.01
  >309.74(3.91–24.26)0.000145.93(5.47–385.91)0.0004
 Genotype 12.65(1.36–5.15)0.0047.78(1.96–30.83)0.004

  • ↵2-150 Time dependent variables.